Expert panel examines myopia control spectacle lenses, pediatric imaging
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 7 October 2026
What it is about
Essilor StellestRudolph WagnerRoberto WarmanAmerican Association For Pediatric OphthalmologyUniversity Of Illinois At ChicagoGenentechWorld CongressRutgers New Jersey Medical SchoolWilmer Eye InstituteAmericanSingaporeChinaNew York, United StatesUniversity Of Illinois At Chicago, Illinois, United StatesIllinois, United StatesFlorida, United StatesMaryland, United StatesMiami, Florida, United States
Who published it, and when
How it spread - 1 original report
Wed, 7 October 2026
1 report- healio.com00:00first to report
The myopia epidemic continues to pose a significant international challenge, but the eye care community has made strides in reducing its progression in pediatric patients. In September 2025, the FDA granted market authorization to Essilor Stellest spectacle lenses (EssilorLuxottica), the first eyeglasses capable of slowing pediatric progression. With the glasses now available in the U.S., Healio